STAT Technologies, Inc.
Distributor of CLIA-waived point-of-care diagnostic devices, consumables, and related services since 1992. Provides product sales through e-commerce and account teams, fulfillment/logistics, equipment rental, training and customer education, and a health data collection and coaching platform. Operates national regional sales coverage and participates in group purchasing programs.
Industries
Nr. of Employees
small (1-50)
STAT Technologies, Inc.
8760 Jefferson Hwy, Maple Grove, MN 55369
Products
Pulse oximeter fingertip O2 saturation monitor
Handheld fingertip pulse oximeter for measuring oxygen saturation and pulse rate; includes batteries and carrying accessories.
PT/INR self-test monitoring system and test strips
Portable PT/INR monitoring system for anticoagulation self-testing with compatible test strips, controls, and accessories.
Point-of-care lipid and glucose test strips and analyzers
Lipid panels, cholesterol and glucose test strips and analyzers for point-of-care screening.
Rapid multi-panel urine drug screen kits
Multi-panel urine drug screening cups and cassette tests covering various analytes for workplace or clinical screening.
A1C mail-in collection kit
Specimen collection kit intended for mail-in laboratory analysis of hemoglobin A1C.
Pulse oximeter fingertip O2 saturation monitor
Handheld fingertip pulse oximeter for measuring oxygen saturation and pulse rate; includes batteries and carrying accessories.
PT/INR self-test monitoring system and test strips
Portable PT/INR monitoring system for anticoagulation self-testing with compatible test strips, controls, and accessories.
Point-of-care lipid and glucose test strips and analyzers
Lipid panels, cholesterol and glucose test strips and analyzers for point-of-care screening.
Rapid multi-panel urine drug screen kits
Multi-panel urine drug screening cups and cassette tests covering various analytes for workplace or clinical screening.
A1C mail-in collection kit
Specimen collection kit intended for mail-in laboratory analysis of hemoglobin A1C.
Services
Warehousing, inventory management, order processing, and distribution services to support national accounts and e-commerce orders.
On-site and remote training for point-of-care device operation and clinical workflows.
Digital platform for collecting health data and delivering coaching services to support wellness programs.
Short-term rental of diagnostic and medical equipment to support events or temporary needs.
Warehousing, inventory management, order processing, and distribution services to support national accounts and e-commerce orders.
On-site and remote training for point-of-care device operation and clinical workflows.
Digital platform for collecting health data and delivering coaching services to support wellness programs.
Short-term rental of diagnostic and medical equipment to support events or temporary needs.
Expertise Areas
- Point-of-care diagnostic distribution
- Supply chain and fulfillment for medical supplies
- Clinical training and device education
- Digital health data collection and coaching
Key Technologies
- Rapid lateral-flow antigen/antibody assays
- Urine multi-panel drug screening
- Handheld/coagulation and glucose analyzers
- Capillary blood collection (lancets, capillary tubes)
News & Updates
Company moved corporate and warehouse address effective October 5, 2024 to 8760 Jefferson Hwy, Maple Grove, MN 55369.
Announcement that the company closed on a merger with Whitmire Medical to expand distribution capabilities.
Company announced assumption of operating accounts of Walltek Medical to expand corporate wellness distribution.
Press release that an offered COVID-19 rapid antibody/IgG/IgM test received FDA emergency use authorization.
Company moved corporate and warehouse address effective October 5, 2024 to 8760 Jefferson Hwy, Maple Grove, MN 55369.
Announcement that the company closed on a merger with Whitmire Medical to expand distribution capabilities.
Company announced assumption of operating accounts of Walltek Medical to expand corporate wellness distribution.
Press release that an offered COVID-19 rapid antibody/IgG/IgM test received FDA emergency use authorization.